Gabapentin helpful for hot flushes in postmenopausal women

,; ,

Q&A

Gabapentin helpful for hot flushes in postmenopausal women

J Fam Pract. 2003 July;52(7):512-525

By

Christopher Haines, MD, MA

Marc I. Harwood, MD

BACKGROUND: Although HRT is effective in reducing hot flushes, recent data from the Women’s Health Initiative and other concerns about estrogen use have limited its use in postmenopausal women. Safe, effective, and well-tolerated therapies for hot flushes would be welcomed.
POPULATION STUDIED: The investigators enrolled 59 postmenopausal women who reported a daily average of 7 or more hot flushes. Study participants were recruited by advertisements and from a local news program about complementary hot flush therapies.
STUDY DESIGN AND VALIDITY: In this randomized, double-blind trial, subjects were assigned to receive 12 weeks of therapy with gabapentin 300 mg capsules 3 times daily (900 mg/d), or matching placebo.
OUTCOMES MEASURED: The primary outcome measure for the double-blinded portion of the study was the percentage change in hot flush frequency from baseline to treatment week 12. Secondary outcome measures included changes in the hot flush composite scores from baseline to week 12.
RESULTS: The gabapentin group experienced a 45% decrease in mean hot flush frequency, compared with a 29% decrease in the placebo group (from 10.8 to 5.9 per day in the gabapentin group and from 10.3 to 7.3 per day in the placebo group; P=.02). The gabapentin group experienced a 54% decrease in the mean hot flush composite score, compared with a 31% decrease in the placebo group (44.9 to 20.5 vs. 39.5 to 27.3; P=.01). This is a significant change, but certainly less than the 90% efficacy that has been observed with HRT.

PDF Download

Gabapentin helpful for hot flushes in postmenopausal women

Recommended Reading